Kinetics and thermodynamics of adsorption on hydroxyapatite of the [160Tb]terbium complexes of the bone-targeting ligands DOTP and BPPED

Simple borophosphate glasses for on-demand growth of self-supported copper nanoparticles in the reduction of 4-nitrophenol

Herein, we demonstrate a single-step synthesis of simple copper-doped borophosphate glasses and their unusual use for catalytic reduction of nitro groups from the aromatic nitro compounds. The copper-doped glasses were evaluated as an affordable heterogeneous catalytic glass-based material for the reduction of 4-nitrophenol by sodium borohydride. The glass matrix acts as a host and support material for in situ self-growth of zero-valent copper (Cu) nanoparticles (NPs) on the glass surface. Thus, zero-valent CuNPs are produced in situ on the glass surface that is accomplished by the interaction of copper ions with hydride ions. Using an intrinsic reaction kinetic constant, we find a catalytic activity of 0.144 L s^-1 g^-1 for a glass-based catalyst doped with a non-noble metal, which is an order of magnitude higher when compared to the values observed elsewhere. Furthermore, the reuse of glass catalyst after six successive cycles demonstrates an outstanding performance compared to that of the parent material. A mathematical model based on the Langmuir-Hinshelwood mechanism related to an empirical growth rate of the zero-valent CuNPs was proposed to describe the kinetic of the 4-nitrophenol catalytic hydrogenation.

Process optimization of polyphenol oxidase immobilization: Isotherm, kinetic, thermodynamic and removal of phenolic compounds

Chitosan/montmorillonite (CTS/MMT) and chitosan‑gold nanoparticles/montmorillonite (CTS-Au/MMT) composites were prepared, characterized through Fourier transformed infrared (FT-IR), X-ray powder diffraction (XRD), and scanning electron microscopy (SEM), and utilized as support for immobilization of polyphenol oxidase (PPO). PPO was immobilized on CTS/MMT (IPPO) and CTS-Au/MMT (IPPO-Au) by physical adsorption, respectively. In order to achieve simultaneous maximization of immobilization efficiency and enzyme activity, the immobilization process parameters were optimized by Taguchi-Grey relational analysis (TGRA) approach. Under the optimal immobilization condition, the immobilization efficiency and enzyme activity reached at 50.16% and 1.46 × 10⁴ U/mg for IPPO, and 63.35% and 3.01 × 10⁴ U/mg for IPPO-Au, respectively. The isotherm, kinetic and thermodynamics of PPO adsorption were investigated in detail. The adsorption process was better explained by Toth isotherm and Fractal-like pseudo second order model, respectively. Intra-particle diffusion and film diffusion were involved in the adsorption process and intra-particle diffusion was not the only rate-controlling step. The adsorption of PPO was exothermic, physical and spontaneous at the investigated temperature range. The immobilized PPO were used to oxidize phenolic compounds. All investigated phenolic compounds showed the higher conversion as catalyzed by IPPO-Au. For both IPPO and IPPO-Au, the conversion of substituted phenols was higher than that of phenol.

Adsorption of the Tartrate Ions in the Hydroxyapatite/Aqueous Solution of NaCl System

The research on the interaction of tartrate ions with the surface of hydroskyapatite was presented, including the measurements of the kinetics of tartrate ion adsorption and tartrate ion adsorption as a function of pH. The adsorption of tartrate ions was calculated from the loss of tartrate concentration in the solution as measured by a radioisotope method using C-14 labeled tartaric acid. In order to explain the mechanism of interaction of tartrate ions with hydroxyapatite, supplementary measurements were carried out, i.e., potentiometric measurements of the balance of released/consumed ions in the hydroxyapatite/electrolyte solution system, zeta potential measurements, FTIR spectrophotometric measurements and the hydroxyapatite crystal structure and particle size distribution were characterized. It was found that the adsorption of tartrate ions occurs as a result of the exchange of these ions with hydroxyl, phosphate and carbonate ions. Replacing the ions with the abovementioned tartrate ions leads to the appearance of a negative charge on the surface of the hydroxapatite. On the basis of XRD study and particle size distribution, a decrease in the size of crystallites and the diameter of hydroxyapatite particles in contact with a solution of 0.001 mol/dm³ of tartaric acid was found.

Local administration and enhanced release of bone metabolic antibodies from hydroxyapatite/chondroitin sulfate nanocomposite microparticles using zinc cations

As a local delivery carrier of bone metabolic proteins, we have previously reported hydroxyapatite/chondroitin sulfate composite microparticles (HAp/ChS) and their formulation method using zinc cations (Zn), and the in vitro release properties of proteins from the microparticles. Herein, we report the release properties of model antibodies such as immunoglobulin (IgG), human IgG (hIgG), and denosumab (Dmab) from HAp/ChS using this formulation method. Adding Zn in the formulation of IgG loaded with HAp/ChS microparticles enhanced the release of antibodies from HAp/ChS in phosphate buffer saline. In addition, the biological activity of Dmab released from HAp/ChS formulated with Zn was significantly higher than that without Zn. These results suggest a possible beneficial effect on the treatment for local bone diseases. The sclerostin monoclonal antibody (Sclmab) promotes fracture healing. We prepared HAp/ChS microparticles loaded with Sclmab and locally administered the microparticles into a drilled hole in the distal femoral bone of young rats. After three weeks, the area of the newly formed osteoid around the drilled hole where HAp/ChS loaded with Sclmab and Zn was locally administered was significantly higher than that observed in the control group (normal saline). Thus, HAp/ChS microparticles and the formulation method of monoclonal antibodies using Zn could be useful in the treatment of local bone diseases.

Influencing the Electron Density of Nanosized Au Colloids via Immobilization on MgO to Stimulate Surface Reaction Activities

Heterogenization of colloidal gold on MgO is demonstrated to facilitate its catalytic surface reactivity. We show that the electron density on Au influenced by its immobilization on MgO along with the ensued metal-support interaction is one of the key parameters to obtain high activity. As elucidated by X-ray absorption spectroscopic (X-ray photoelectron spectroscopy, X-ray absorption near-edge structure, and extended X-ray absorption fine structure) studies, the presence of well-dispersed nanosized Au on MgO is observed to result in an enhancement in the electron density of Au. The consequence of this electron-rich gold on the catalytic activity is then investigated using the nitroarene reduction as a model reaction with a detailed kinetic study. The kinetic study is an attempt to use a true heterogeneous system rather than the usually studied quasi-homogeneous systems. The results obtained reveal that the Au/MgO catalyst has a surface rate constant of ∼1.39 × 10^-3 mol m^-2 s^-1, which is significantly higher than those of the reported catalysts. While it validates the higher catalytic activity with a TOF of 9456 h^-1 observed for Au/MgO, the increased adsorption constant for 4-nitrophenol on Au/MgO further reflects the efficacy of MgO as the support. This not only allows effective heterogenization of the Au nanoparticles keeping the catalyst stable under the reaction conditions and being reused several times but also renders a capability in reduction of other nitro group-containing substrates. Therefore, the results are believed to be of importance in designing heterogeneous catalysts utilizing the distinctive properties of the nanosized colloids and tuning their surface reactivity as well.

Kinetic Analysis of 4-Nitrophenol Reduction by "Water-Soluble" Palladium Nanoparticles

The most important model catalytic reaction to test the catalytic activity of metal nanoparticles is the reduction of 4-nitrophenol to 4-aminophenol by sodium borohydride as it can be precisely monitored by UV–vis spectroscopy with high accuracy. This work presents the catalytic reduction of 4-nitrophenol (4-Nip) to 4-aminophenol (4-Amp) in the presence of Pd nanoparticles and sodium borohydride as reductants in water. We first evaluate the kinetics using classical pseudo first-order kinetics. We report the effects of different initial 4-Nip and NaBH₄ concentrations, reaction temperatures, and mass of Pd nanoparticles used for catalytic reduction. The thermodynamic parameters (activation energy, enthalpy, and entropy) were also determined. Results show that the kinetics are highly dependent on the reactant ratio and that pseudo first-order simplification is not always fit to describe the kinetics of the reaction. Assuming that all steps of this reaction proceed only on the surface of Pd nanoparticles, we applied a Langmuir−Hinshelwood model to describe the kinetics of the reaction. Experimental data of the decay rate of 4-nitrophenol were successfully fitted to the theoretical values obtained from the Langmuir–Hinshelwood model and all thermodynamic parameters, the true rate constant k, as well as the adsorption constants of 4-Nip, and BH₄⁻ (K_4-Nip and K_BH4−) were determined for each temperature.

Eu-Doped Citrate-Coated Carbonated Apatite Luminescent Nanoprobes for Drug Delivery

In the field of Nanomedicine, there is an increasing demand for new inorganic nanophosphors with low cytotoxicity and efficient loading-release ability of drugs for applications in bioimaging and drug delivery. This work assesses the potentiality of matured Eu-doped citrate-coated carbonated apatite nanoparticles to be used as theranostic platforms, for bioimaging, as luminescent nanoprobes, and for drug delivery applications, using Doxorubicin as a model drug. The drug adsorption isotherm fits the Langmuir-Freundlich (LF) model, showing that the Eu:cit-cAp nanoparticles can carry a maximum of 0.29 ± 0.02 mg Doxo mg Eu:cit-cAp-1 (Qmax). The affinity constant KFL for this binding is 44 ± 2 mL mg-1, and the cooperativity coefficient r is 6 ± 1. The nanoparticle suspensions presented charge reversion from negative to positive after loading with Doxo as revealed by the ζ-potential versus pH characterization. The release of drug from the loaded nanoparticles was found to be strongly pH-dependent, being around 5 wt % at physiological pH 7.4 and 20 wt % at pH 5, in experiments lasting 24 h. Luminescence spectroscopic measurements of Doxo-loaded nanoparticles revealed the increase of luminescence with a decrease in the amount of adsorbed Doxo, due to the so-called inner filter effect. The nanoparticles free of Doxo were cytocompatible when interacted with two human cell lines derived respectively from a gastric carcinoma (GTL-16), and a hepatocarcinoma (Huh7), while Doxo-loaded nanoparticles displayed significant toxicity in a dose-dependent relationship. Therefore, the new nanoassemblies might have a dual function, as nanoprobes in bioimaging by detecting the fate of the nanoparticles in biological environments, and for monitoring the delivery of the drug in such environments, by measuring the rise of the luminescence provided by the desorption of Doxo.

pH-Dependent Adsorption Release of Doxorubicin on MamC-Biomimetic Magnetite Nanoparticles

New biomimetic magnetite nanoparticles (hereafter BMNPs) with sizes larger than most common superparamagnetic nanoparticles were produced in the presence of the recombinant MamC protein from Magnetococcus marinus MC-1 and functionalized with doxorubicin (DOXO) intended as potential drug nanocarriers. Unlike inorganic magnetite nanoparticles, in BMNPs the MamC protein controls their size and morphology, providing them with magnetic properties consistent with a large magnetic moment per particle; moreover, it provides the nanoparticles with novel surface properties. BMNPs display the isoelectric point at pH 4.4, being strongly negatively charged at physiological pH (pH 7.4). This allows both (i) their functionalization with DOXO, which is positively charged at pH 7.4, and (ii) the stability of the DOXO-surface bond and DOXO release to be pH dependent and governed by electrostatic interactions. DOXO adsorption follows a Langmuir-Freundlich model, and the coupling of DOXO to BMNPs (binary biomimetic nanoparticles) is very stable at physiological pH (maximum release of 5% of the drug adsorbed). Conversely, when pH decreases, these electrostatic interactions weaken, and at pH 5, DOXO is released up to ∼35% of the amount initially adsorbed. The DOXO-BMNPs display cytotoxicity on the GTL-16 human gastric carcinoma cell line in a dose-dependent manner, reaching about ∼70% of mortality at the maximum amount tested, while the nonloaded BMNPs are fully cytocompatible. The present data suggest that BMNPs could be useful as potential drug nanocarriers with a drug adsorption-release governed by changes in local pH values.

Kinetic Study of the Bioadsorption of Methylene Blue on the Surface of the Biomass Obtained from the Algae D. antarctica

Currently, there is a great pollution of water by the dyes; due to this, several studies have been carried out to remove these compounds. However, the total elimination of these pollutants from the aquatic effluents has represented a great challenge for the scientific community, for which it is necessary to carry out investigations that allow the purification of water. In this work, we studied the bioadsorption of methylene blue on the surface of the biomass obtained from the algae D. antarctica. This material was characterized by SEM and FTIR. To the data obtained in the biosorption experiments, different models of biosorption and kinetics were applied, finding that the best fit to the obtained data is given by applying the pseudo-second-order models and the Toth model, respectively. It was also determined that the maximum adsorption capacity of MB on the surface of the biomass is 702.9 mg/g, which shows that this material has great properties as a bioadsorbent.

Adsorption of reactive dyes onto chitosan/montmorillonite intercalated composite: multi-response optimization, kinetic, isotherm and thermodynamic study

Chitosan/montmorillonite intercalated composite (CTS/MMT) was used as an effective adsorbent for removal of reactive dyes, i.e. Reactive Black 5 (RB5), Reactive Red 136 (RR136), Reactive Yellow 145 (RY145) and Reactive Blue 222 (RB222). Taguchi method attached grey relational analysis was applied to determine the optimal adsorption conditions, including pH, initial concentration of dye, temperature, adsorbent dosage and contact time, for achieving simultaneous maximization of removal percentage and adsorption capacity. The percentage contribution of each adsorption condition was determined in the analysis of variance and showed that the most effective parameter in removal of RB5, RY145 and RB222 is the dye solution pH, whereas the initial concentration was the determining factor for optimum efficiency for the dye RR136. Under respective optimal condition, the removal percentages and adsorption capacity of four reactive dyes onto CTS/MMT were both found in the following order: RR136 > RY145 > RB5 > RB222. The maximum removal percentages of 78.8 and 49.5%, and the adsorption capacity of 315.20 and 123.75 mg/g were obtained for RR136 and RB222, respectively. The adsorption behaviors showed that the adsorption kinetics and isotherms were in best agreement with Avrami fractionary order model and the Toth isotherm, respectively.

Phosphonic acid: preparation and applications

The phosphonic acid functional group, which is characterized by a phosphorus atom bonded to three oxygen atoms (two hydroxy groups and one P=O double bond) and one carbon atom, is employed for many applications due to its structural analogy with the phosphate moiety or to its coordination or supramolecular properties. Phosphonic acids were used for their bioactive properties (drug, pro-drug), for bone targeting, for the design of supramolecular or hybrid materials, for the functionalization of surfaces, for analytical purposes, for medical imaging or as phosphoantigen. These applications are covering a large panel of research fields including chemistry, biology and physics thus making the synthesis of phosphonic acids a determinant question for numerous research projects. This review gives, first, an overview of the different fields of application of phosphonic acids that are illustrated with studies mainly selected over the last 20 years. Further, this review reports the different methods that can be used for the synthesis of phosphonic acids from dialkyl or diaryl phosphonate, from dichlorophosphine or dichlorophosphine oxide, from phosphonodiamide, or by oxidation of phosphinic acid. Direct methods that make use of phosphorous acid (H3PO3) and that produce a phosphonic acid functional group simultaneously to the formation of the P-C bond, are also surveyed. Among all these methods, the dealkylation of dialkyl phosphonates under either acidic conditions (HCl) or using the McKenna procedure (a two-step reaction that makes use of bromotrimethylsilane followed by methanolysis) constitute the best methods to prepare phosphonic acids.

Targeted delivery to bone and mineral deposits using bisphosphonate ligands

The high concentration of mineral present in bone and pathological calcifications is unique compared with all other tissues and thus provides opportunity for targeted delivery of pharmaceutical drugs, including radiosensitizers and imaging probes. Targeted delivery enables accumulation of a high local dose of a therapeutic or imaging contrast agent to diseased bone or pathological calcifications. Bisphosphonates (BPs) are the most widely utilized bone-targeting ligand due to exhibiting high binding affinity to hydroxyapatite mineral. BPs can be conjugated to an agent that would otherwise have little or no affinity for the sites of interest. This article summarizes the current state of knowledge and practice for the use of BPs as ligands for targeted delivery to bone and mineral deposits. The clinical history of BPs is briefly summarized to emphasize the success of these molecules as therapeutics for metabolic bone diseases. Mechanisms of binding and the relative binding affinity of various BPs to bone mineral are introduced, including common methods for measuring binding affinity in vitro and in vivo. Current research is highlighted for the use of BP ligands for targeted delivery of BP conjugates in various applications, including (1) therapeutic drug delivery for metabolic bone diseases, bone cancer, other bone diseases, and engineered drug delivery platforms; (2) imaging probes for scintigraphy, fluorescence, positron emission tomography, magnetic resonance imaging, and computed tomography; and (3) radiotherapy. Last, and perhaps most importantly, key structure-function relationships are considered for the design of drugs with BP ligands, including the tether length between the BP and drug, the size of the drug, the number of BP ligands per drug, cleavable tethers between the BP and drug, and conjugation schemes.

In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp)3 and La(XT), for the treatment of bone resorption disorders

Bone density diseases such as osteoporosis affect a significant number of people worldwide. Lanthanide ions are functional mimics of calcium ions, able to substitute for Ca2+ in the bone mineral component, hydroxyapatite (HAP). Bone undergoes a continuous remodelling cycle and lanthanides can affect this cycle, exerting a positive influence on bone mineral. We have been engaged in efforts to find new lanthanide containing complexes as active agents for treatment of these diseases and have identified two lead compounds, 3-hydroxy-1,2-dimethylpyridin-4(1H)-one (Hdpp) and a phosphinate-EDTA derivative, bis[[bis(carboxymethyl)amino]-methyl]phosphinate (H5XT). In this paper, we report in vivo data for the first time for the two lead compounds. The pharmacokinetics of La(dpp)3 suggest the complex is rapidly cleared from plasma. We demonstrate that La3+ accumulates in the bone following IV dose of either La(dpp)3 or La(XT) and we have investigated the influence of each chelating ligand on the incorporation of La3+ into HAP using ITC and HAP-binding studies.

Synthesis and preliminary in vivo evaluation of well-dispersed biomimetic nanocrystalline apatites labeled with positron emission tomographic imaging agents

In recent years, biomimetic synthetic apatite nanoparticles (AP-NPs), having chemical similarity with the mineral phase of bone, have attracted a great interest in nanomedicine as potential drug carriers. To evaluate the therapeutic perspectives of AP-NPs through the mechanisms of action and organs they interact with, the noninvasive monitoring of their in vivo behavior is of paramount importance. To this aim, here the feasibility to radiolabel AP-NPs ("naked" and surface-modified with citrate to reduce their aggregation) with two positron emission tomographic (PET) imaging agents ([(18)F]NaF and (68)Ga-NO2AP(BP)) was investigated. [(18)F]NaF was used for the direct incorporation of the radioisotope into the crystal lattice, while the labeling by surface functionalization was accomplished by using (68)Ga-NO2AP(BP) (a new radio-metal chelating agent). The labeling results with both tracers were fast, straightforward, and reproducible. AP-NPs demonstrated excellent ability to bind relevant quantities of both radiotracers and good in vitro stability in clinically relevant media after the labeling. In vivo PET studies in healthy Wistar rats established that the radiolabeled AP-NPs gave significant PET signals and they were stable over the investigated time (90 min) since any tracer desorption was detected. These preliminary in vivo studies furthermore showed a clear ability of citrated versus naked AP-NPs to accumulate in different organs. Interestingly, contrary to naked AP-NPs, citrated ones, which unveiled higher colloidal stability in aqueous suspensions, were able to escape the first physiological filter, i.e., the lungs, being then accumulated in the liver and, to a lesser extent, in the spleen. The results of this work, along with the fact that AP-NPs can be also functionalized with targeting ligands, with therapeutic agents, and also with metals for a combination of different imaging modalities, make AP-NPs very encouraging materials for further investigations as theranostic agents in nanomedicine.

A bottom-up approach to understanding protein layer formation at solid-liquid interfaces

A common goal across different fields (e.g. separations, biosensors, biomaterials, pharmaceuticals) is to understand how protein behavior at solid-liquid interfaces is affected by environmental conditions. Temperature, pH, ionic strength, and the chemical and physical properties of the solid surface, among many factors, can control microscopic protein dynamics (e.g. adsorption, desorption, diffusion, aggregation) that contribute to macroscopic properties like time-dependent total protein surface coverage and protein structure. These relationships are typically studied through a top-down approach in which macroscopic observations are explained using analytical models that are based upon reasonable, but not universally true, simplifying assumptions about microscopic protein dynamics. Conclusions connecting microscopic dynamics to environmental factors can be heavily biased by potentially incorrect assumptions. In contrast, more complicated models avoid several of the common assumptions but require many parameters that have overlapping effects on predictions of macroscopic, average protein properties. Consequently, these models are poorly suited for the top-down approach. Because the sophistication incorporated into these models may ultimately prove essential to understanding interfacial protein behavior, this article proposes a bottom-up approach in which direct observations of microscopic protein dynamics specify parameters in complicated models, which then generate macroscopic predictions to compare with experiment. In this framework, single-molecule tracking has proven capable of making direct measurements of microscopic protein dynamics, but must be complemented by modeling to combine and extrapolate many independent microscopic observations to the macro-scale. The bottom-up approach is expected to better connect environmental factors to macroscopic protein behavior, thereby guiding rational choices that promote desirable protein behaviors.

Poly(γ-benzyl-L-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting

Hydroxyapatite (HAP), a highly specific component of bone tissue, is the main target in order to impart osteotropicity. Bone targeted nanoparticles can increase the strength of the interaction with HAP through multivalency and thus constitute a valuable strategy in the therapeutics of skeletal diseases. PBLG10k-b-PEG6k-alendronate nanoparticles (~ 75 nm) were prepared by a simple nanoprecipitation method. The calcium affinity (KCa(+2)=1.8 × 10(4)M(-1)) of these nanoparticles was evaluated using isothermal titration calorimetry. The multivalent interaction with HAP surfaces (KHAP) was studied by fluorescence and was estimated to be 1.1 × 10(10)M(-1), which is more than 4000 times stronger than the reported monovalent interaction between alendronate and HAP surfaces. Molecular modeling suggests that the number of binding sites available at the HAP surface is in large excess than what is required for the whole surface coverage by alendronate decorated nanoparticles. The lower calcium affinity of these nanoparticles than for HAP allows calcium bound nanoparticles to interact with HAP, which yields a deeper understanding of bone targeted carriers and could potentially improve their bone targeting properties.

pH-responsive delivery of doxorubicin from citrate-apatite nanocrystals with tailored carbonate content

In this work, the efficiency of bioinspired citrate-functionalized nanocrystalline apatites as nanocarriers for delivery of doxorubicin (DOXO) has been assessed. The nanoparticles were synthesized by thermal decomplexing of metastable calcium/citrate/phosphate solutions both in the absence (Ap) and in the presence (cAp) of carbonate ions. The presence of citrate and carbonate ions in the solution allowed us to tailor the size, shape, carbonate content, and surface chemistry of the nanoparticles. The drug-loading efficiency of the two types of apatite was evaluated by means of the adsorption isotherms, which were found to fit a Langmuir-Freundlich behavior. A model describing the interaction between apatite surface and DOXO is proposed from adsorption isotherms and ζ-potential measurements. DOXO is adsorbed as a dimer by means of a positively charged amino group that electrostatically interacts with negatively charged surface groups of nanoparticles. The drug-release profiles were explored at pHs 7.4 and 5.0, mimicking the physiological pH in the blood circulation and the more acidic pH in the endosome-lysosome intracellular compartment, respectively. After 7 days at pH 7.4, cAp-DOXO released around 42% less drug than Ap-DOXO. However, at acidic pH, both nanoassemblies released similar amounts of DOXO. In vitro assays analyzed by confocal microscopy showed that both drug-loaded apatites were internalized within GTL-16 human carcinoma cells and could release DOXO, which accumulated in the nucleus in short times and exerted cytotoxic activity with the same efficiency. cAp are thus expected to be a more promising nanocarrier for experiments in vivo, in situations where intravenous injection of nanoparticles are required to reach the targeted tumor, after circulating in the bloodstream.

Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates

In the present study two nanocrystalline apatites have been investigated as bone-specific drug delivery devices to be used for treatment of bone tumors either by local implantation or by injection. In order to assess how the Ca/P ratio can influence the adsorption and release of anticancer platinum-bisphosphonate complexes, two kinds of apatite nanocrystals having different Ca/P ratios but similar morphologies, degree of crystallinity, and surface areas have been synthesized and characterized. The two platinum-bisphosphonate complexes considered were the bis-{ethylenediamineplatinum(ii)}-2-amino-1-hydroxyethane-1,1-diyl-bisphosphonate and the bis-{ethylenediamineplatinum(ii)}medronate. The Ca/P ratio plays an important role in the adsorption as well as in the release of the two drugs. In fact, the apatite with a higher Ca/P ratio showed greater affinity for both platinum complexes. Also the chemical structure of the two Pt complexes appreciably affects their affinity towards as well as their release from the two kinds of apatites. In particular, the platinum complex whose bisphosphonate contains a free aminic group showed greater upload and smaller release. The cytotoxicity of the Pt complexes released from the apatite was tested against human cervical, colon, and lung cancer cells as well as against osteosarcoma cells. In agreement with previous work, the Pt complexes released were found to be more cytotoxic than the unmodified complexes.

Bisphosphonates as radionuclide carriers for imaging or systemic therapy

Bisphosphonates (BP's), biologically stable analogs of naturally occurring pyrophosphates, became the treatment of choice for pathologic conditions characterized by increased osteoclast-mediated bone resorption, namely Paget's disease, osteoporosis and tumor bone disease. Moreover, the clinical success of BP's is also associated with their use in (99m)Tc-based radiopharmaceuticals for bone imaging. In addition to the successful delivery of (99m)Tc (γ-emitter) to bone, BP's have also been used to deliver β(-)-particle emitting radiometals (e.g.(153)Sm, (186/188)Re) for bone-pain palliation. The main goal of this Review is to update the most recent research efforts toward the synthesis, characterization and biological evaluation of novel BP-containing radiometal complexes and radiohalogenated compounds for diagnostic or therapeutic purposes. The structure and in vivo properties of those compounds will be discussed and compared to the clinically available ones, namely in terms of image quality and therapeutic effect. We will also mention briefly the use of BP's as carriers of multimodal nuclear and optical imaging probes.

Polyacrylamide-clinoptilolite/Y-zeolite composites: characterization and adsorptive features for terbium

The composites of natural (clinoptilolite) and synthetic zeolite (Z and YZ) with polyacrylamide (PAAm) were synthesized and characterized by FT-IR, TGA, XRD, SEM and PZC analysis. The adsorptive features of the minerals and its composites were investigated for Tb analogues to the rare earth elements (REs) by isotopic tracer method, (160)Tb was the radiotracer. The composites were the hybrid formations of PAAm and Z or YZ. Tb adsorption capacities of the composites were higher than those of bare Z and YZ. The compatibility of Tb adsorption kinetics to the second order and Weber-Morris models implied that the sorption process was chemical via ion exchange. The values of enthalpy and entropy changes were positive and the negative free enthalpy change was evidence for the spontaneity of adsorption. The reusability tests for the composites for five uses demonstrated that the adsorbents could be reused after complete recovery of the loaded ion. Unlike PAAm-YZ, PAAm-Z was resistant to acidic environment. The overall results eventually suggested that the composite of Z and PAAm was a potential cost effective adsorbent for Tb(3+) and REs.

Bone-seeking probes for optical and magnetic resonance imaging

In clinical practice the imaging of bone tissue is based almost exclusively on x-ray or radiochemical methods. Alternative methods, such as MRI and optical imaging, can provide not only anatomical, but also physiological information, due to their ability to reflect the properties of body fluids (temperature, pH and concentration of ions). In this article we review bone targeting probes for MRI and fluorescence imaging. As bone targeting is mainly associated with phosphonate and bisphosphonate derivatives, we also focus on their sorption behavior. Also discussed in detail is the limitation of using bone-targeting probes for MRI and optical imaging mainly due to their long-time retention in bone tissue and the low permeability of tissues for light.